Publications by authors named "Michael De Lay"

Claim this Profile
H
Hydration solids.
Steven G Harrellson, Michael S DeLay, Xi Chen, Ahmet-Hamdi Cavusoglu, Jonathan Dworkin

Nature· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer.
Arman Jahangiri, Alan Nguyen, Ankush Chandra, Maxim K Sidorov, Garima Yagnik, Michael De Lay

Proc Natl Acad Sci U S A· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLUT3 upregulation promotes metabolic reprogramming associated with antiangiogenic therapy resistance.
Ruby Kuang, Arman Jahangiri, Smita Mascharak, Alan Nguyen, Ankush Chandra, Michael De Lay

JCI Insight· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scaling up nanoscale water-driven energy conversion into evaporation-driven engines and generators.
Xi Chen, Davis Goodnight, Zhenghan Gao, Ahmet H Cavusoglu, Nina Sabharwal, Michael DeLay

Nat Commun· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β1 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastoma.
W Shawn Carbonell, Michael DeLay, Arman Jahangiri, Catherine C Park, Manish K Aghi

Cancer Res· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance.
Arman Jahangiri, Michael De Lay, Liane M Miller, W Shawn Carbonell, Yu-Long Hu

Clin Cancer Res· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia-induced tumor cell autophagy mediates resistance to anti-angiogenic therapy.
Yu-Long Hu, Arman Jahangiri, Michael De Lay, Manish K Aghi

Autophagy· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microarray analysis verifies two distinct phenotypes of glioblastomas resistant to antiangiogenic therapy.
Michael DeLay, Arman Jahangiri, W Shawn Carbonell, Yu-Long Hu, Sean Tsao

Clin Cancer Res· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma.
Yu-Long Hu, Michael DeLay, Arman Jahangiri, Annette M Molinaro, Samuel D Rose

Cancer Res· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells.
Jakub Godlewski, Michal O Nowicki, Agnieszka Bronisz, Gerard Nuovo, Jeff Palatini, Michael De Lay

Mol Cell· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia.
Amy J Johnson, David M Lucas, Natarajan Muthusamy, Lisa L Smith, Ryan B Edwards, Michael D De Lay

Blood· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis